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1078–5884/00The Combined Effect of Iloprost and N-Acetylcysteine in
Preventing Spinal Cord Ischemia in Rabbits
M. Boga,1* B. Discigil,1 E.A. Ozkisacik,1 U. Gurcun,1 M.I. Badak,1 E. Dikicioglu,2
C. Yenisey3 and I. Meteoglu2Departments of 1Cardiovascular Surgery, 2Pathology, and 3Biochemistry, Medical Faculty, Adnan Menderes
University, Aydin, TurkeyObjectives. This study investigated the cytoprotective effects of N-acetylcysteine (NAC) and iloprost on spinal cord
ischemia in an experimental model.
Materials and methods. Thirty-five (male) New Zealand white rabbits were included in five study groups (nZ7, each
group). One group served as Sham. Rabbits in other groups had their abdominal aorta cross-clamped just above the iliac
bifurcation for 40 min. During aortic cross clamping, iloprost, NAC, both iloprost and NAC or saline (control) were infused.
Results. In NAC, iloprost, and iloprostCNAC groups, neurological status of rabbits (Tarlov score) 24 and 48 h after the
operation was better than the control group (p!0.01), but worse than the Sham group (p!0.01). There was minimal
neuronal damage in the iloprost treated groups compared to the NAC group (p!0.05). Mean viability index values in NAC,
iloprost and iloprostCNAC groups were higher than the control group (p!0.01). Viability index in the NAC group was
lower than the iloprost and iloprostCNAC groups.
Conclusions. The use of iloprost and NAC may provide better protection from spinal cord ischemia.Key words: Iloprost; N-acetylcysteine; Ischemic spinal cord injury.Introduction
Spinal cord ischemic injury is one of the feared
complications following cross clamping of the des-
cending thoracic or thoracoabdominal aorta.1 Numer-
ous spinal cord protection methods including
temporary shunts or partial bypass, hypothermia,
drainage of cerebrospinal fluid, and pharmacologic
measures are currently in use to prevent ischemic
spinal cord injury.2–6 Pharmacologic research such as
use of steroids, oxygen-derived free radical scaven-
gers, vasodilators, and drugs designed to achieve
spinal cord electrical silence during ischemia-reperfu-
sion is of continuing interest.7–10 Neuronal cell death
during ischemia is thought to be due to free radical
generation, lipid peroxidation, and the accumulation
of intracellular calcium.11,12
Glutathione is present in high concentration in most
of the cells which have antioxidant properties.13
Cysteine is the precursor of glutathione and is ining author. Mehmet Boga, MD, Department of Cardi-
rgery, Medical Faculty, Adnan Menderes University,
Turkey.
: mboga@adu.edu.tr
0366+ 07 $35.00/0 q 2005 Elsevier Ltd. All rights reserclinical use as N-acetylcysteine (NAC). This thiol-
containing compound used for treating bronchitis has
been shown to exert a protective effect against brain
injury caused by temporary bilateral carotid occlusion
in Mongolian gerbils.14 Prostacyclin (PGI2) with its
cytoprotective, antioxidant, and vasodilator effects
may reduce spinal cord injury during aortic occlu-
sion.15–17 Iloprost is one of the stable analogs of PGI2
and has been reported to have a similar profile of
action as PGI2.18
The aim of this study was to assess the combined
cytoprotective effects of NAC and iloprost on spinal
cord ischemia in an experimental model.Material and MethodAnimal care
All animals were given 5 days of adaptation to their
environment prior to experiments. This work was
approved by the Animal Care Committee of the
Adnan Menderes University. All animals received
humane care, in compliance with the ‘Guide forEur J Vasc Endovasc Surg 31, 366–372 (2006)
doi:10.1016/j.ejvs.2005.10.027, available online at http://www.sciencedirect.com onved.
N-Acetylcysteine and Iloprost in Spinal Cord Protection 367the care and use of laboratory animals’ published
by the National Institute of Health (NIH Publication
5377-3, 1996).Anesthesia and monitoring
Anesthesia was induced by intramuscular ketamine
(50 mg/kg) and xylazine (5 mg/kg); then maintained
by an additional one-quarter single dose of this
combination given intravenously in the middle of the
operation. Animals were allowed to breathe spon-
taneously and core temperature was monitored with a
rectal probe. Each procedure was performed in the
same operating room at ambient temperature. A
catheter (24 gauge) was placed in an ear vein to give
maintenance fluid (0.9% saline solution at a rate of
20 mL/h). An arterial catheter (24 gauge) was placed
in an ear artery to monitor blood pressure (monitor
model 275 Petas KMA Ankara Turkey).Operative technique
Animals were placed in supine position. After sterile
preparation, a 10-cm midline incision was made, and
the infrarenal abdominal aorta was exposed through a
transperitoneal approach with the abdominal contents
reflected to the right. The aorta was isolated from the
left renal artery down to the aortic bifurcation. Each
animal was given 150 U/kg heparin intravenously
5 min prior to aortic occlusion. Heparin was not
reversed at the end of the procedure. The aorta was
cross-clamped just below the left renal artery and just
proximal to the aortic bifurcation by using arterial
bulldog clamps (Vascu-statt, Scanlan, USA). The
inferior mesenteric artery was also clamped at its
origin from the aorta, and loss of aortic pulse was
confirmed by palpation. All animals were subjected to
40 min of cross-clamp time. Aortic clamps were
removed after 40 min, and it was verified that
satisfactory aortic pulse returned. The abdomen was
closed in layers and the catheters were removed.
Sham-operated animals underwent the same operat-
ive conditions, but without aortic occlusion. Animals
were allowed to recover in their cages, with free access
to food and water in the postoperative period.Study groups
All animals were randomly assigned into one of five
study groups. The experiment was continued until
seven animals in each group survived the entire
procedure. All animals received a similar volume ofmaintenance fluids (20 mL/h saline) for the whole
procedure. The five groups were:
† Sham group (nZ7). The operation was performed
in the same fashion, but without aortic occlusion.
† Control group (nZ7). The animals received only
0.9% saline.
† Group iloprost (nZ7). Iloprost was infused at a rate
of 25 ng/kg/min started with laparotomy and
ceased after aortic cross-clamp was released.
† Group NAC (nZ7). NAC was infused at a rate of
20 mg/kg/h during aortic cross clamping
following a bolus IV dose of 20 mg/kg.
† Group iloprostCNAC (nZ7). Both iloprost and
NAC were infused simultaneously.
A total of seven animals died during the procedure,
one at the adaptation period, three in control groupdue
to hemorrhage or anesthetic induction, one in ilo-
prostCNACgroupduring anesthetic induction, two in
iloprost group due to hypotension and they were all
excluded. Thirty-five male New Zealand white rabbits
(mean weight 2200G300 g, range 1750–3100 g), which
survived throughout the entire procedure were
included in the study (nZ7 in each group).Neurologic evaluation
A neurological assessment was performed in all
animals by an independent observer who was blinded
to the groups in the postoperative 24th and 48th h.
Spinal cord function was graded according to a
modified Tarlov scale as follows: 0, paraplegic with
no movement; 1, poor lower extremity function; 2,
some lower extremity function with good antigravity
strength, sits with assistance; 3, sits alone and weak
hop; 4, normal motor function, hop.19Sacrifice and tissue preparation
All animals were killed at 48 hours postoperatively by
a lethal cardiac injection of pentobarbital (100 mg/kg).
Spinal cords were harvested immediately; and the L3–
L6 segments (6–8 cm in length) were fixed in 10%
neutrally tamponaded formalin solution and stored
for 24 hours, before being embedded in paraffin blocks
for sectioning and histologic examination.Histopathologic examination
Sections 4–7 mm in thickness obtained from distal
caudal portions of the harvested spines correspondingEur J Vasc Endovasc Surg Vol 31, April 2006
M. Boga et al.368to L5–L6 segments were affixed to glass slides, then
stained with Hematoxylin–Eosin (H–E) and examined
by light microscopy. The extent of ischemic damage
and leukocyte infiltration in motor neurons in ventral
horns of spinal cord were assessed. Cells, which had
eosinophilic cytoplasm and lost their nucleus, were
considered as injured. Neurons, which had prominent
nucleolus with fine chromatins and contained cyto-
plasmic nissle bodies were considered as viable cells.
The neurons from each spinal cord section were
examined and categorized as injured or viable by a
blinded observer. Viability index was then calculated
by dividing the number of viable cells by the total
number of neurons counted within the entire micro-
scopic section for each animal (viability indexZ
number of viable cells/total number of neurons). In
addition, the inflammatory response was also graded
semi-quantitavely by counting the number of leuko-
cytes that infiltrated in randomly selected fields and
scored according to the number leukocytes as
following: ‘0’ for none, ‘1’ for less than 20, ‘2’ for 20
to 50, ‘3’ for more than 50 leukocytes.Biochemical analysis
Blood samples were drawn after the induction of
anesthesia (pre-ischemia), and two hours following
release of aortic cross clamping (post-ischemia) via the
ear artery catheter. Blood was allowed to clot for 20–
30 min at room temperature and then centrifuged
(5000 rpm, 10 min atC4 8C) and kept frozen atK85 8C
until studied. Samples were analyzed for neuron-
specific enolase (NSE) and nitric oxide (NO; nitriteC
nitrate).
NSE was measured by using a commercial kit
(Roche, Cat. No. 12133121-122) via Moduler E170
hormone autoanalyzer. This method is based on
chemiluminescent enzyme immunoassay and results
were expressed as mg/l. There was no significant red
blood cell hemolysis in any of the samples studied.
NO (nitriteCnitrate) was assayed by a modification
of cadmium-reduction method as reported by
Navarro-Gonzalves.20 The nitrite produced was deter-
mined by diazotization of sulphanilamide and coup-
ling to naphthlethylene diamine. For the measurement
of NO (nitriteCnitrate), a 400 ml sample was
denatured by adding 80 ml 30% ZnSO4 solution,
stirring and then centrifuging at 10,000 g for 20 min
at 4 8C. Cd granules were activated using CuSO4
solution in glycine–NaOH buffer. Then 100 ml of
deproteinized samples and standards were added.
This reaction uses pre-treatment of samples to reduce
nitrate to nitrite, which can be accomplished byEur J Vasc Endovasc Surg Vol 31, April 2006catalytic reactions using enzyme or Cd. The samples
were analyzed spectrophotometrically using a micro-
plate reader and quantified automatically against a
KNO3 standard curve and the results expressed as
mM/l.Statistical analysis
Mann–Whitney U test was used to compare the
neurological and pathological findings among differ-
ent groups. For comparisons made within each group,
Wilcoxon Signed Rank test was used. All data are
presented as meansGSD. Intergroup and intragroup
mean values were compared by repeated measures
ANOVA and post hoc Turkey. Differences were
considered to be significant when p!0.05.ResultsPhysiologic parameters
There was no significant difference in the physiologi-
cal parameters between experimental and control
groups at any time measured (Table 1).Neurological outcome
Rabbits in Sham-operated group did not have any
neurologic deficit. However, all rabbits in control
group showed severe neurologic deficits including
total paraplegia in five (Table 2). At 24 and 48 h the
neurological status of the rabbits in the NAC, iloprost,
and iloprostCNAC groups were worse than in the
Sham group (p!0.01, Tables 2 and 3), but better than
the control animals (p!0.01, Tables 2 and 3). The
neurological status of animals in group NAC was
significantly worse than the other two iloprost treated
groups in the first 48 h (Tables 2 and 3). We observe
only minimal neuronal damage in the iloprost treated
groups, while the lesions weremore severe in the NAC
group (Fig. 2).Histopathologic examination
Sham-operated animals had spinal cords with high
viability indices. Extensive ischemic damage was
observed in ventral horns of spinal cords harvested
from the animals in the control group which was
consistent with the low viability index (Figs. 1 and 2).
All animals in NAC, iloprost and iloprostCNAC
groups had viability index values not statistically
Table 1. Physiologic and hemodynamic measurements
Sham (nZ7) Control (nZ7) Iloprost (nZ7) NAC (nZ7) IloprostCNAC
(nZ7)
Weight (gram) 2385G365 2157G258.9 2350G287 2228.8G184 2171G470
Mean arterial pressure
(mmHg)
Before laparotomy 67G13 63G7 59G7 61G6 64G9
During aortic
occlusion
– 69G5 67G8 69G8 70G7
After operation, 5th
min
61G7 59G7 53G7 56G8 56G5
Rectal temperature (8C)
Before laparotomy 39.2G0.3 38.9G0.2 38.9G0.2 38.8G0.4 38.9G0.3
During aortic
occlusion
– 38.7G0.4 38.9G0.3 39.0G0.2 39.0G0.1
After operation, 5th
min
38.6G0.2 38.6G0.4 38.4G0.4 38.7G0.3 38.6G0.4
Heart rate (beat/min)
Before laparotomy 181G7 178G9 187G9 180G14 187G6
During aortic
occlusion
186G11 189G8 185G8 185G7
After operation, 5th
min
184G8 187G9 188G10 191G10 192G9
NAC, N-acetylcysteine.
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index values in NAC, iloprost and iloprostCNAC
groups were statistically higher than the control group
(p!0.01, Table 3, Fig. 1) indicating lesser or no
neuronal damage. Even though the animals in NAC
group had higher viability index values compared to
controls, the ratios of viable cells remained lower
compared to iloprost and iloprostCNAC groups;
however, it did not reach to statistical significance.
The mean grading score of inflammatory response of
iloprostCNAC animals was close to the sham group
and significantly less than the control animals and
NAC treated animals (Table 3).Biochemical analysisSerum NSE levels
There was a significant rise in post-ischemia serum
NSE levels in all control animals compared to pre-
ischemia levels. This rise was not observed in NAC,
iloprost, sham and NACCiloprost groups. NSE levels
obtained in NAC, iloprost and NACCiloprost groupsTable 2. Neurological outcome of rabbits according to Tarlov score
Tarlov
score
Group Sham (nZ7) Group control (nZ7) Group
24 h 48 h 24 h 48 h 24 h
0 5 5
1 2 1 4
2 1 3
3
4 7 7
NAC, N-acetylcysteine.were significantly lower than control group but not
than the sham group. There was no difference between
NAC, iloprost and NACCiloprost groups in terms of
pre- and post-ischemia serum NSE levels (Table 4).
Serum NO (nitriteCnitrate)
Post-ischemia values of serum NO levels increased in
control group and decreased in NAC, iloprost and
NACCiloprost groupwhen compared to pre-ischemia
values obtained within each group, however, differ-
ences did not reach to statistical significance. NO
levels obtained in NAC, iloprost and NACCiloprost
groups were significantly lower than the control group
but not the sham group (Table 4).Discussion
The results of this study clearly demonstrated that
aortic occlusion causes severe injury of the spinal cord
when no pharmacological agents are used. We
demonstrated more extensive spinal cord injury in
animals with more neurological functional deficit.
Using the pharmacological agents NAC and iloprostNAC (nZ7) Group iloprost (nZ7) Group iloprostCNAC
(nZ7)
48 h 24 h 48 h 24 h 48 h
1
5 6 4 3 2
1 1 3 4 3
2
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Table 3. Comparison of neurological outcome and histopathologic findings
Groups Tarlov score PO 24 h Tarlov score PO 48 h Viability index Inflammatory response
Sham 4.0G0.00* 4.00G0.00* 0.83G3.90* 0.57G0.53*
Control 0.28G0.48† 0.42G0.78† 0.13G8.93† 2.14G0.90†
NAC 1.42G0.53*,†,‡,§ 2.00G0.57*,†,‡ 0.57G0.32* 1.71G0.50‡
Iloprost 2.14G0.37*,†,§ 2.42G0.53*,† 0.78G8.80* 1.14G0.70
IloprostCNAC 2.57G0.53*,†,‡ 3.00G0.81*,†,‡ 0.76G8.26* 0.86G0.70*,‡
NAC, N-acetylcysteine, PO, post-operative.
* p!0.01 when compared to control group.
† p!0.01 when compared to Sham group.
‡ p!0.01 for NAC versus IloprostCNAC.
§ p!0.05 for NAC versus Iloprost.
M. Boga et al.370we were able to reduce spinal cord ischemic injury
with the combined infusion being most effective.
Aortic occlusion results in spinal cord neuronal
injury due to both cessation of blood flow leading to
loss of oxygen and nutrient supply and the initiation of
secondary mechanisms such as free radical generation,
lipid peroxidation, and the accumulation of intracellu-
lar calcium.12,14,21 This neurotoxicity involves deterio-
ration in normal metabolic and physiological
functions resulting in cell death. Reinstitution of
blood flow and limiting the secondary neurotoxic
cascades are necessary to prevent ischemic neuronal
damage. Iloprost is reported to have neuroprotective
effects against ischemia-induced injury.22–24 NAC, a
low molecular weight thiol compound has been
shown to have antioxidant properties by replenishing
intracellular reduced glutathione and scavenging
reactive oxygen species including hydroxyl radical.25
This study confirms that a bolus dose of NAC given
before aortic occlusion followed by continuous infu-
sion of NAC throughout the ischemic period maySham Control NAC Iloprost Iloprost+NAC
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Fig. 1. Comparison of cytoarchitecture of spinal cords
expressed by viability index values. Higher viability index
indicates lesser neuronal damage. All numbers are
expressed as means. For each group, nZ7. (*) p!0.01
when compared to control group. (&) p!0.01 when
compared to Sham group.
Eur J Vasc Endovasc Surg Vol 31, April 2006result in significant spinal cord protection in parallel
with previous studies.7 Similarly, iloprost infusion
started before aortic occlusion and continued through-
out the ischemia may also result in significant spinal
cord protection which is consistent with the findings of
several studies.8,26,27 The addition of iloprost to NAC
improved neurological outcome, compared with NAC
given alone, suggesting that a synergistic effect exits
for these drugs when given in combination (p!0.01).
The cytoprotective effect of NAC is attributed to its
regulatory role on microcirculatory blood flow and
tissue oxygenation.14,28,29 It could be speculated that
the vasodilating and anti-aggregating effects of
iloprost might enhance NAC penetration into the
spinal cord under ischemia. The iloprostCNAC
combination also enhanced NAC to exert its known
effect of reducing the recruitment of leucocytes into the
inflammatory site. This was consistent with the
finding that the inflammatory response following
ischemia-reperfusion was significantly less in NACC
iloprost animals compared to controls (p!0.01).
The neuronal cytoarchitecture was assessed using
viability scoring. Neuronal viability was better pre-
served when NAC or iloprost was used. This
preservation was more prominent when iloprost or
combination of iloprost and NAC was used (Fig. 1).
NSE was analyzed in order to monitor tissue
destruction in spinal cord ischemic injury. NSE,
neuronal form of the intracytoplasmic glycolytic
enolase is found in neuronal cell bodies, axons, and
neuroendocrine cells and in neuroendocrine tumors.30
It is well documented that significant increases are
observed in blood levels of NSE in the early period
following neuronal injury.31 In the present study,
blood NSE levels was found to be higher in the post-
ischemic period indicating severe spinal cord ischemia
in control animals. This rise in blood NSE levels was
not observed in animals received pharmacological
protection during ischemia (p!0.01).
NO, a free radical has been implicated as one of the
mediators of neuronal damage following ischemia.
Neuronal damage following vascular stroke has been
Fig. 2. Representative photographs of spinal cord sections with hematoxylin and eosin. Neuronal cells are well preserved
with sham operated group (A), necrotic neurons with control group (B), minimal evidence of cellular damage with iloprost
treated group (C), evidence of cellular damage with N acetyl-cysteine treated group (D), grossly normal neurons with
iloprostCN acetyl-cysteine treated group (E). Normal motor neuron (arrows), necrotic motor neuron (arrowheads).
Table 4. Comparison of changes in biochemical markers
Sham Control Iloprost NAC IloprostCNAC
NSE (mg/L)
Pre-ischemia 5.33G1.16 5.41G1.07 4.51G1.00 5.60G0.8 5.57G1.56
Post-ischemia 4.99G1.33 7.86G2.16*,† 4.66G1.03‡ 4.90G0.93‡ 4.66G1.30‡
NO (mM/L)
Pre-ischemia 33.44G5.91 31.67G11.18 38.23G6.11 33.63G11.76 34.18G13.30
Post-ischemia 33.48G6.30 47.88G16.40 29.42G3.51§ 29.17G13.72§ 25.62G11.31‡
NAC, N-acetylcysteine, NSE, neuron-specific enolase, and NO, nitric oxide metabolites nitrite and nitrate.
* p!0.01 when compared with Sham group.
† p!0.05 when pre-ischemia and post-ischemia values are compared.
‡ p!0.01 when compared with control group.
§ p!0.05 when compared with control group.
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M. Boga et al.372shown to be markedly diminished in animals with NO
synthase inhibitors.21 NAC has been reported to
inhibit NO production; and this effect was thought to
be due to removal of superoxide anion and inhibition
of NO synthase activity.14 Severe spinal cord ischemia
generated in the present model resulted in significant
rise in blood NO levels. The blood NO levels were all
found to be lower in all animals where the spinal cord
was protected by pharmacological means.
In conclusion, iloprost and NAC in combination
may provide better protection of the spinal cord from
ischemic injury.References
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